Where Do We Stand With Immune Checkpoint Blockade for Advanced Cutaneous Squamous Cell Carcinoma? A Systematic Review and Critical Appraisal of Existing Evidence

British Journal of Dermatology - United Kingdom
doi 10.1111/bjd.18957
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Comparison of Guidelines for the Management of Patients With High‐risk and Advanced Cutaneous Squamous Cell Carcinoma – A Systematic Review

Journal of the European Academy of Dermatology and Venereology
DermatologyInfectious Diseases
2019English

Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Platinum and Anthracycline Therapy for Advanced Cutaneous Squamous Cell Carcinoma

International Journal of Clinical Oncology
MedicineSurgeryOncologyHematology
2012English

Medical Treatment of Advanced Cutaneous Squamous‐cell Carcinoma

Journal of the European Academy of Dermatology and Venereology
DermatologyInfectious Diseases
2019English

Transitional Cell Carcinoma of the Bladder in Pediatric Patients: Where Do We Stand?

Urologia Colombiana
Urology
2020English

Immune Checkpoint Blockade for Hematologic Malignancies: A Review

Stem Cell Investigation
2017English

CD147 Expression in Advanced Cutaneous Squamous Cell Carcinoma

Journal of Cutaneous Pathology
DermatologyForensic MedicinePathologyHistology
2012English

Second-Line Treatment of Advanced Gastric Cancer: Where Do We Stand?

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2015English

Clinical Impact of Tumoral Angiogenesis on Renal Cell Carcinoma Management: Where Do We Stand?

Expert Review of Precision Medicine and Drug Development
Molecular MedicineDrug DiscoveryGeneticsPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy